Aripiprazole for Injection Lyophilized powder 0.3g Low price wholesale

DescriptionAripiprazole is an atypical antipsychotic widely recognized for its novel mechanism of action as a dopamine D2 receptor partial agonist and serotonin 5-HT1A/5-HT2A modulator. The injectable form offers targeted delivery for research involving rapid-onset pharmacokinetics and neurobehavioral models.This lab-grade injectable is supplied as a 0.3g lyophilized powder, ideal for applications in neuroscience, CNS studies, and antipsychotic drug screening. Contents hide 1 Aripiprazole for Injection Product Specifications 2 Aripiprazole for Injection Mechanism of Action 3 Research Applications 4 Safety Profile & Handling 5 Core Keywords 6 Research Use Only Disclaimer Aripiprazole for Injection Product SpecificationsParameterDetailsProduct NameAripiprazole for InjectionGeneric NameAripiprazoleCAS Number129722-12-9Molecular FormulaC??H??Cl?N?O?Molecular Weight448.38 g/molFormulationLyophilized powder for injectionStrength0.3g per vialPackaging1 vial per boxDosage FormInjection (Freeze-dried powder)Approval NumberHJ20230054 (NMPA, China)ManufacturerOtsuka Pharmaceutical Co., Ltd. (Tokushima Wajiki Factory)StorageStore at 2–8°C; protect from light and moistureIntended UseLaboratory research onlyAripiprazole for Injection Mechanism of ActionAripiprazole acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and an antagonist at 5-HT2A receptors. This unique mechanism helps regulate dopaminergic and serotonergic activity in the brain—making it ideal for investigating schizophrenia, bipolar disorder, and neuropsychiatric modeling in lab settings.Research ApplicationsPsychopharmacology: Commonly used in behavioral assays and animal models of psychosis and schizophrenia.CNS Receptor Binding Studies: Useful for analyzing D2, D3, and 5-HT receptor profiles.Drug Metabolism: Supports in vitro and in vivo PK/PD research on metabolic pathways.Combination Therapy Research: Can be evaluated alongside mood stabilizers or antidepressants in lab settings.Safety Profile & HandlingCommon Lab Observations: Sedation, behavioral changes in animal models, injection site irritation.Handling: Use gloves, mask, and aseptic technique. Reconstitute with sterile water as per instructions.Stability: Lyophilized powder stable for 24 months when stored at 2–8°C. Use reconstituted solution promptly.Core KeywordsAripiprazole, Aripiprazole for Injection, CAS 129722-12-9, dopamine D2 partial agonist, atypical antipsychotic research, CNS pharmacology, lyophilized injection, lab-grade Aripiprazole, neuropsychiatric research, schizophrenia drug model, Otsuka PharmaceuticalResearch Use Only DisclaimerThis product is strictly for laboratory research use. It is not intended for human, veterinary, therapeutic, or diagnostic applications. Use only in accordance with institutional safety guidelines.